Apple has reportedly been approved by the Korean Ministry of Food and Drug Safety (MFDS) to use its electrocardiogram (ECG) feature in the Apple Watch according to Patently Apple. Apple introduced a new feature in the Apple Watch Series 4 which would allow it to measure electrical signals across the heart as well as look for irregular heart rhythm.
As South Korea begins to ease excessive regulations on medical devices, companies are expected to compete and gain dominance over the “healthcare” market. Whether Apple will turn on the ECG feature in their Series 4 and Series 5 Apple Watches or waits for the launch of Apple Watch Series 6 is yet to be known.
Last month Apple received approval from Brazil’s Health Regulatory Agency (ANVISA) as well as registration as a certified manufacturer in Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), MacOtakara reports. Although the Japanese documents aren’t clear on what this registry is about, it is very likely that Apple has been authorized to use the ECG feature in Japan.
Apple has already received approval for its ECG feature from the US Food and Drug Administration as well as Europe and Hong Kong.